CD44 and cancer: These findings, however, were not associated with a cancer stem cell signature dictated by the CD44High/CD24Low phenotype [43] because both sHCC29 and sHCC63 cells were CD44−/CD24−, whereas sHCC74 and SAR-HCV cells were CD44+/CD24−.